Purdue Pharma
The state may have a tougher case: “It looks more like they are trying to browbeat Johnson & Johnson into settling.”
The billionaire family, which owns OxyContin maker Purdue Pharma, distanced itself from the addiction crisis in a letter of warning.
The Guggenheim Museum in New York and the Tate galleries in the U.K. have said they won't accept more money from the Sackler Trust.
The New York museum’s decision follows similar moves by museums in London amid the ongoing opioid crisis.
WHAT'S HAPPENING
The charitable organization tied to the Sackler family, which owns OxyContin manufacturer Purdue Pharma, said it had “jointly agreed not to proceed.”
As OxyContin addiction spurred a national nightmare, a member of the family that has reaped billions of dollars from the painkiller boasted that sales exceeded his “fondest dreams.”
This lesser known case against Purdue Pharma in Oklahoma is set to be the first of the 330 state and federal lawsuits on opioids to go to trial.
Purdue Pharma, which is owned by the Sackler family, manufactures and markets OxyContin -- one of the prescription painkillers at the center of the opioid crisis.
Federal regulator slammed as Massachusetts sues billionaire Sacklers for pushing OxyContin.
The pharmacies are accused of failing to stop opioid orders that were suspicious or of an unreasonable amount.